SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (1783)8/15/2003 7:58:56 PM
From: SemiBull  Respond to of 3044
 
Abbott Labs, Millennium end research alliance

Friday August 15, 7:10 pm ET

LOS ANGELES, Aug 15 (Reuters) - Medical product maker Abbott Laboratories Inc. (NYSE:ABT - News) and biotechnology company Millennium Pharmaceuticals Inc. (NasdaqNM:MLNM - News) said on Friday they have ended an alliance to develop and commercialize diabetes and obesity drugs.

Abbott, based in Abbott Park, Illinois, said it retains a license to targets, compounds and certain technologies that were the subject of the collaboration and will continue to independently develop the most promising compounds.